Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Fitzroy, Australia.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Genetic Technologies Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Genetic Technologies Ltd. market cap is $1,300.00.
What is the 52-week high for Genetic Technologies Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Genetic Technologies Ltd. 52 week high is $1.00 as of October 02, 2025.
What is the 52-week low for Genetic Technologies Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Genetic Technologies Ltd. 52 week low is $0.00 as of October 02, 2025.
What was Genetic Technologies Ltd. stock price yesterday?
Genetic Technologies Ltd. stock price yesterday was $1.00.
What is the PE ratio of Genetic Technologies Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Genetic Technologies Ltd.’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Genetic Technologies Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Genetic Technologies Ltd. P/B ratio is -0.0001.
What is the 50-day moving average of Genetic Technologies Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Genetic Technologies Ltd. 50-day moving average is $0.06.